LA
Lishan Aklog
Chairman and CEODirector

Lishan Aklog insider trades: PAVmed (PAVM) stock purchases

Chairman and CEO, PAVmed Last trade Mar 18, 2021 48 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
14
Open-market trades
since 2016
4
Companies
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Lishan reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 18, 2021PAVM↑ Buy$32K
May 23, 2019PAVM↑ Buy$33K
Aug 28, 2018PAVM↑ Buy$35K
Sep 12, 2017PAVM↑ Buy$666
Aug 16, 2017PAVM↑ Buy$4K
Aug 16, 2017PAVM↑ Buy$985
Aug 16, 2017PAVM↑ Buy$941
Nov 29, 2016PAVM↑ Buy$26K
Nov 23, 2016PAVM↑ Buy$20K
Nov 21, 2016PAVM↑ Buy$23K
Sep 16, 2016PAVM↑ Buy$18K
Sep 14, 2016PAVM↑ Buy$20K
Aug 26, 2016PAVM↑ Buy$6K
Aug 24, 2016PAVM↑ Buy$21K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Lishan Aklog's insider trades

Lishan Aklog is Chairman and CEO at PAVmed (PAVM). Since Aug 24, 2016, Lishan has reported 14 open-market purchases worth $241K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include other transactions (20 filings), grants and awards (17 filings), gifts (2 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PAVM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.